About Canada's Research-Based Pharmaceutical Companies
Canada’s Research-Based Pharmaceutical Companies is the national association representing the voice of Canada’s innovative pharmaceutical industry. We serve our membership by advocating for policies that enable the discovery, development and delivery of innovative medicines and vaccines to improve the lives of all Canadians. We support our memberships’ commitment to being a valued partner in the Canadian healthcare system. We represent more than 50 companies investing over $1-billion in R&D annually, fuelling Canada’s knowledge-based economy, while contributing over $3-billion overall to Canada’s economy. Guided by our Code of Ethical Practices, we work with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.
Canadians living healthier and longer lives through access to innovative medicines and vaccines.
As the national voice of research-based pharmaceutical companies, Rx&D advocates for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members commitment to being valued partners in the Canadian healthcare system.
- Become an authentic, solution-driven partner through effective alliances, policy and leadership.
- Improve the access and regulatory environment in Canada.
- Advocate for a globally competitive Intellectual Property (IP) regime.